Intended for healthcare professionals

News

AstraZeneca vaccine: Blood clots are “extremely rare” and benefits outweigh risks, regulators conclude

BMJ 2021; 373 doi: https://doi.org/10.1136/bmj.n931 (Published 08 April 2021) Cite this as: BMJ 2021;373:n931

Read our latest coverage of the coronavirus pandemic